Despite promising signs that Peru’s new president was ready to take a fresh approach to drug policy, focused on attacking traffickers and not coca farmers, his unorthodox top drug official has resigned and been replaced with a more Washington-friendly choice. Ricardo Soberon’s appointment as head of national anti-drug agency Devida was viewed by many as a sign that newly-appointed President Ollanta Humala planned to reform Peru’s anti-narcotics policy. Soberon's proposed policies involved moving away from attacking coca growers.
The loudest voices in US drug policy debates call either for enforcing prohibition with ever-increasing ferocity or for giving up altogether by letting corporations legally sell the currently illicit drugs much as they do tobacco and alcohol. But as our colleagues and we detail this week in the Lancet, there is an alternative: adopting drug policies with scientific evidence of effectiveness. Regardless of what goals for drug policy emerge from the democratic process, everyone wants the policies implemented in the service of those goals to be effective.